BIOSPECIFICS TECHNOLOGIES CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
BIOSPECIFICS TECHNOLOGIES CORP had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $3.09 million as of 2018-12-31, per its 10-K filed 2019-04-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2019-04-02
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.09M.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $4.97M.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $9.48M.
- 2014-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $24.40M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2018-12-31 | $3.09M 10-K · filed 2019-04-02 |
| 2017-12-31 | $4.97M 10-K · filed 2018-03-14 |
| 2016-12-31 | $9.48M 10-K · filed 2017-03-16 |
| 2014-09-30 | $24.40M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $16.90M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $18.40M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $14.80M 10-K · filed 2014-03-07 |
| 2013-09-30 | $8.20M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $8.20M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $9.90M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $8.00M 10-K · filed 2013-03-15 |
| 2012-09-30 | $13.60M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $13.20M 10-Q · filed 2012-08-09 |